LUMOS DIAGNOSTICS HOLDINGS LIMITED

Press Releases Lumos Diagnostics Holdings Limited

Equities

LDX

AU0000157091

Market Closed - Australian S.E. Other stock markets 07:10:14 09/05/2024 BST			5-day change	1st Jan Change
0.05 ^AUD	-1.96%		+2.04%	-31.51%

05-06	Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6%	MT
04-09	Lumos Diagnostics' FebriDx May Help Optimize Antibiotic Use in Children with Febrile Respiratory Infections, Study Shows	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lumos Diagnostics Appoints Doug Ward as CEO	21/06/22	GL
Lumos Diagnostics Appoints Doug Ward as CEO	21/06/22	AQ
Lumos Diagnostics : Letter to Eligible Shareholders	10/06/22	PU
Lumos Diagnostics : Operational Update and Accelerated Entitlement Offer	06/06/22	PU
Lumos Diagnostics : Notification regarding unquoted securities - LDX	01/04/22	PU
Lumos Diagnostics : FY2022 Half Year Update	27/02/22	PU
Lumos Diagnostics : Appendix 4D and Half Year Report	27/02/22	PU
Liverpool CCG and Community Pharmacy Liverpool Launch FebriDx® Service at More Than 100 Community Pharmacies	12/01/22	BU
Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada	03/11/21	BU
Lumos Diagnostics : Economic Evaluation of Lumos Diagnostics’ FebriDx® Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually	06/10/21	BU
Lumos Diagnostics : Dr. Jerome Adams, Former U.S. Surgeon General, Joins Lumos Diagnostics as a Strategic Healthcare Adviser	14/09/21	BU
Lumos Diagnostics : FY21 Full Year Results	31/08/21	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer